Roche inaugurated its new Institute of Human Biology research facility in Basel, aiming to accelerate drug discovery by pioneering human model systems like organoids and organ-on-chip technologies combined with AI. This CHF 1.4 billion investment supports Roche's commitment to Switzerland and advances biomedical research by bridging fundamental science and industry applications. The institute houses up to 250 researchers and focuses on creating predictive models to improve understanding of human diseases and speed up development of new treatments. This initiative is part of Roche's broader CHF 3.5 billion annual research investment and long-term strategy to innovate in healthcare.
The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...
The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...
New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...
A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
